Taiho Seeks Additional Gastric Cancer Indication For Abraxane
This article was originally published in PharmAsia News
Executive Summary
Taiho Pharmaceutical Corp. has submitted an application for Abraxane (paxlitacel) for an additional indication to treat gastric cancer in Japan.